The patent cliff is here. With it comes an onslaught of blockbuster brand-name drugs whose market exclusivity runs out, thus clearing the way for significantly lower-price prescription drugs which represent newfound revenue and profit for retail pharmacies and billions in health care savings for their patients. At the same time as this new wave of generics hits the market, other events are transpiring that could threaten generic dispensing and pharmacy revenues. Those events are part ...

REGISTER TO VIEW THIS ARTICLE - Register for a Free Account

Why Register for FREE?

Registering for content on Supermarket News will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’s FREE, easy and quick.  What are you waiting for! In addition you will also receive a complimentary copy of SN's salary survey sent to you by email.

Click here to read the FAQ page if you have any questions (opens in a new window)

Attention Paid Print Subscribers:  While you have already been granted free access to SN we ask that you register now. We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.

Already registered? here.